Medication info
Tamitra Tablet

Tamitra Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Samik Pharmaceuticals Co., Ltd.
Appearance
Light yellow, rectangular film-coated tablets
Packaging
(Domestic use) 30 tablets/bottle, 100 tablets/bottle (Export) 100 tablets (10 tablets/PTP*10)
Approval status
Active

MFDS item code 200804611 · Notified 2008.04.24 · Insurance code 644002040

Summary

Main use
Relief of moderate~severe acute·chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Pediatric patients aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the total dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Samik Pharmaceuticals Co., Ltd.

Efficacy & effects

Relief of moderate~severe acute·chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Pediatric patients aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the total dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may burden the liver; therefore, individuals who regularly consume more than three glasses of alcohol daily should consult a doctor or pharmacist before using it. This medication can, though rarely, cause serious skin reactions; if a rash or hypersensitivity occurs, use should be discontinued immediately and medical advice sought. The ingredients in this medication may increase the risk of seizures; therefore, patients with a history of seizures or at risk for seizures should use it cautiously, and caution is required when taken with certain antidepressants or opioid pain relief medications. Serious allergic reactions, such as anaphylaxis, may rarely occur; if symptoms such as difficulty breathing or hives appear, immediate medical attention is required. Patients with acute bronchial asthma are at risk of severe respiratory depression when taking this medication; therefore, it should be administered in a medically equipped environment, and other analgesics are preferable. Using this medication alongside alcohol or benzodiazepine medications can lead to severe drowsiness, respiratory depression, or coma, so co-administration should be avoided or used for the shortest duration at minimum dosages. Patients with elevated intracranial pressure or head injuries should be cautious with this medication, as respiratory depression can further elevate brain pressure. This medication can lead to psychological and physical dependence; therefore, continuous monitoring for dependency is necessary when used for extended periods. Patients with liver dysfunction might experience liver damage due to the acetaminophen component of this medication and should consult with a physician before use. Those who metabolize this medication rapidly due to genetic factors are at risk for severe respiratory depression; thus, careful dose adjustment and monitoring are required. This medication should not be used by children under 12 or by adolescents under 18 who have undergone tonsillectomy or adenoidectomy, and it is advisable to avoid use in cases of sleep apnea. Patients with symptoms of sleep apnea or hypoxia may experience worsening of symptoms after taking this medication; therefore, symptom changes should be carefully monitored, and dosing may need to be reduced or stopped as needed. Hyponatremia can occur during use, so especially elderly patients and those with risk factors should be monitored closely for symptoms. This medication should not be administered to patients with certain conditions or diseases, such as severe respiratory depression, head injuries, those taking MAO inhibitors, or patients with severe liver or kidney impairment. When taking this, the recommended dosage should not be exceeded, and it should not be combined with other medications of similar ingredients. Abruptly stopping this medication may lead to withdrawal symptoms; therefore, doses should be gradually reduced according to a physician's instructions. This medication can cause allergic reactions or severe skin adverse reactions; if abnormal symptoms occur, immediately discontinue use and consult a medical professional. This medication may interact with various other medications; therefore, if you are taking other drugs, be sure to inform your doctor or pharmacist, particularly regarding antidepressants, antibiotics, antifungals, and central nervous system depressants. Elderly patients may be at increased risk of side effects due to declining liver, kidney, and heart function or accompanying diseases, requiring careful administration. Women who are pregnant or may become pregnant should consult a doctor regarding the effects on the fetus before taking this medication, and nursing mothers are advised to avoid breastfeeding while using this medication. This medication can cause drowsiness or dizziness; therefore, it is best to avoid dangerous activities such as driving or operating machinery after taking it. In cases of overdose, severe respiratory depression, seizures, liver damage, etc., can occur; thus, dosage must be strictly adhered to, and in case of overdose, emergency treatment should be sought immediately. Lastly, this medication should be stored in a safe place out of children's reach to prevent accidental ingestion or misuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, carbon dioxide retention, respiratory suppression, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, hives, hypersensitivity, hypoglycemia, anxiety, neurobehavioral hyperactivity, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, paresthesia, attention deficit, fainting, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, thoracic discomfort, malaise, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, impact on emotional instability, delirium, suicidal ideation, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, walking difficulties, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hematologic disorders, hyponatremia, fixed rash, nausea, constipation, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, congestive heart failure, drowsiness, insomnia, decreased appetite, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased erythrocytes, leukopenia, leukocytosis, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, chills, buttock pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, cholecystitis, paralytic ileus, hiccups, abnormal kidney function tests, increased salivation, chest pain, rigidity, fainting, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air infiltration, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Light yellow, rectangular film-coated tablets

Package unit

(Domestic use) 30 tablets/bottle, 100 tablets/bottle (Export) 100 tablets (10 tablets/PTP*10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.